Evidence map›Paper›PMID 26111340›Full record

ArticleeLife2015

ATF4 licenses C/EBPβ activity in human mesenchymal stem cells primed for adipogenesis.

Daniel M Cohen, Kyoung-Jae Won, Nha Nguyen, Mitchell A Lazar, Christopher S Chen, David J Steger

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniel M CohenDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Kyoung-Jae WonThe Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Nha NguyenThe Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Mitchell A LazarDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Christopher S ChenDepartment of Biomedical Engineering, Boston University, Boston, United States.
David J StegerDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
University of Pennsylvania · USBoston University · US

Funding

VIRAL VECTOR COREP30DK019525 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MITCHELL A. LAZAR · 1986 to 2026
$48.3M
Nuclear Receptors in Metabolic TissuesR01DK049780 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LAZAR, MITCHELL A. · 1995 to 2025
$10.8M
Mesenchymal Stem Cells and the MicroenvironmentR01GM074048 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI CHEN, CHRISTOPHER S · 2006 to 2013
$2.5M
Transcriptional and epigenomic control of adipose tissue development and functionR01DK098542 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI STEGER, DAVID J. · 2013 to 2017
$1.7M
An Integrative Approach to Construct a Regulatory Network Effected by TDZsR21DK098769 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI WON, KYOUNG JAE · 2013 to 2014
$440k
Cell contact-driven myogenesis via N-cadherin signalingF32HL084966 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI COHEN, DANIEL M · 2006 to 2007
$90k
NHLBI NIH HHS 1F32 HL084966NHLBI NIH HHS F32 HL084966NIDDK NIH HHS P30 DK019525NIDDK NIH HHS R01 DK049780NIDDK NIH HHS R01 DK098542NIDDK NIH HHS R01 DK49780NIDDK NIH HHS R21 DK098769NIGMS NIH HHS R01 GM074048
6 · The paper itself

Abstract

A well-established cascade of transcription factor (TF) activity orchestrates adipogenesis in response to chemical cues, yet how cell-intrinsic determinants of differentiation such as cell shape and/or seeding density inform this transcriptional program remain enigmatic. Here, we uncover a novel mechanism licensing transcription in human mesenchymal stem cells (hMSCs) adipogenically primed by confluence. Prior to adipogenesis, confluency promotes heterodimer recruitment of the bZip TFs C/EBPβ and ATF4 to a non-canonical C/EBP DNA sequence. ATF4 depletion decreases both cell-density-dependent transcription and adipocyte differentiation. Global profiling in hMSCs and a novel cell-free assay reveals that ATF4 requires C/EBPβ for genomic binding at a motif distinct from that bound by the C/EBPβ homodimer. Our observations demonstrate that C/EBPβ bridges the transcriptional programs in naïve, confluent cells and early differentiating pre-adipocytes. Moreover, they suggest that homo- and heterodimer formation poise C/EBPβ to execute diverse and stage-specific transcriptional programs by exploiting an expanded motif repertoire.

Indexed as

AdipogenesisCell DifferentiationGene Expression RegulationActivating Transcription Factor 4CCAAT-Enhancer-Binding Protein-betaDNAGene Expression ProfilingHumansMesenchymal Stem CellsMolecular Sequence DataProtein BindingSequence Analysis, DNAActivating Transcription Factor 4ATF4 protein, humanCCAAT-Enhancer-Binding Protein-betaCEBPB protein, humanDNAadipogenesischromosomesdevelopmental biologygene expressiongeneshumanmousestem cellstranscription factors

Identifiers

PMID26111340
PMCPMC4501333
OpenAlexW1956993157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.